Abstract The International Federation for the Surgery of Obesity and Metabolic Disorders
(IFSO) issued a position statement on the role of one anastomosis gastric bypass (OAGB) in …

The following position statement is issued by the American Society for Metabolic and
Bariatric Surgery in response to inquiries made to the society by patients, physicians, society …

Background Marginal ulcer (MU) is an uncommon but significant complication following one-
anastomosis gastric bypass (OAGB). Our study aims to understand the incidence rates, risk …

The objective of this review is to systematically review the efficacy and safety outcomes of
one anastomosis gastric bypass (OAGB) with Roux-en-Y gastric bypass (RYGB). From …

In recent years, combined restrictive and hypo-absorptive procedures have gained
widespread acceptance. The rationale of this systematic review is to compare the safety and …

Background Gastroesophageal reflux disease (GERD), including erosive esophagitis, is
highly prevalent in the obese population. Barrett's esophagus is the consequence of …

Background One-anastomosis gastric bypass (OAGB) is a well-established treatment
method in patients with morbid obesity. Its long-term impact on de novo reflux, anastomotic …

This systematic review and meta-analysis aimed to investigate the incidence of new-onset
gastroesophageal reflux, reflux change, esophagitis, Barrett's esophagus, and revision due …

Background: One-anastomosis gastric bypass (OAGB) is an emerging metabolic bariatric
surgery (MBS) type used in both primary OAGB (pOAGB) and revisional OAGB (rOAGB). We …

Background The multicentre randomised trial YOMEGA (NCT02139813) comparing the one
anastomosis gastric bypass (OAGB) with the Roux-en-Y gastric bypass (RYGB) confirmed …